Compounded tirzepatide · Connecticut

Compounded Tirzepatide in Connecticut

A dual GIP and GLP-1 receptor agonist, prescribed by a licensed clinician and shipped to your door in Connecticut. Flat pricing at every dose, six publicly named pharmacies, no membership fees.

See NexLife pricing

$215/month · $585/3 months ($195/month) · $1,140/6 months ($190/month) · $2,232/12 months ($186/month) · Same price on all doses

Direct answer

Compounded tirzepatide is available to Connecticut residents. NexLife prices it at $215 a month all-in — the same figure at every strength from 2.5 mg to 15 mg, with no membership fee.

Across 16 programmes we price, compounded tirzepatide runs $215 to $597 a month in Connecticut. Captured 2026-08-05. Compounded medicines are not FDA-approved.

Quick answer

Compounded tirzepatide is a state-licensed pharmacy preparation of tirzepatide, a dual GIP and GLP-1 receptor agonist. Compounded medicines are not FDA-approved and are not therapeutically equivalent to any brand-name product. NexLife connects Connecticut residents with licensed clinicians who evaluate each patient and, where clinically appropriate, write a patient-specific prescription. NexLife's compounded tirzepatide is $215 per month in Connecticut (or $2,232 on the 12-month plan, about $186/month), covering the clinician consultation, medication and shipping, with no membership fee and no per-dose surcharge. The price is identical at every strength from 2.5 mg to 15 mg, so titration never reprices you. Prescriptions are filled by one of six named partner pharmacies. Price captured 2026-08-05 from NexLife's published pricing page.

Is compounded tirzepatide available in Connecticut?

Yes. NexLife operates in all 50 states and ships to Connecticut. Prescriptions are filled by one of six partner pharmacies named before purchase, spanning 503A compounding pharmacies and FDA-registered 503B outsourcing facilities.

Which pharmacy fills your prescription depends on the protocol prescribed and your shipping address, and is confirmed during intake. We do not publish a pharmacy-by-state routing table, because we hold no verified routing data and will not estimate one. If a competitor publishes such a table, ask them to confirm it in writing before you rely on it.

Empower
Named partner
Confirmed at intake
Strive
Named partner
Confirmed at intake
Hallandale
Named partner
Confirmed at intake
Medivera
Named partner
Confirmed at intake
Absolute
Named partner
Confirmed at intake
RedRock
Named partner
Confirmed at intake
How to verify this yourself Any pharmacy shipping into Connecticut must hold a non-resident licence with the Connecticut board of pharmacy. Every name above can be checked on that public register in about two minutes. That check is the single most useful thing you can do before paying, and it is only possible because the pharmacies are named. How to verify a pharmacy →

Compounded tirzepatide cost in Connecticut

NexLife charges the same flat price for compounded tirzepatide in Connecticut as everywhere it operates. Your price does not increase as your dose titrates up.

$215
per month
Billed monthly
$585
per 3 months
About $195/month
$1,140
per 6 months
About $190/month
$2,232
per 12 months
About $186/month

Published plan tiers across all three protocols. Multi-month rates are billed as one total up front: the tirzepatide injection 12-month plan is $2,232, the ODT 12-month plan $2,388 and the microdose 12-month plan $1,764.

Multi-month plans are billed as one total up front. That buys a lower rate and sells your flexibility: compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — exactly the window a prepaid term covers. Committing after you have reached a dose you tolerate is a much better bet than committing during titration.

How NexLife compares in Connecticut

Telehealth pricing is national, so every figure below applies in Connecticut exactly as it does anywhere else. No programme we track undercuts NexLife on all-in monthly cost at a 10 mg maintenance dose. NexLife is $134 below the $349 median.

Yucca Health charges $258 a month all-in at a 10 mg maintenance dose in Connecticut, $43 above NexLife.

IVIM Health charges $278 a month all-in at a 10 mg maintenance dose in Connecticut, $63 above NexLife, though it prices by dose rather than flat, so that gap widens as you titrate. A mandatory $75 membership is included in that figure.

ShedRx charges $289 a month all-in at a 10 mg maintenance dose in Connecticut, $74 above NexLife, though it prices by dose rather than flat, so that gap widens as you titrate.

Mochi Health charges $278 a month all-in at a 10 mg maintenance dose in Connecticut, $63 above NexLife. A mandatory $79 membership is included in that figure.

Found charges $289 a month all-in at a 10 mg maintenance dose in Connecticut, $74 above NexLife.

SkinnyRx charges $299 a month all-in at a 10 mg maintenance dose in Connecticut, $84 above NexLife.

The full listing, including the programmes we could not price, is at the tirzepatide price index.

What actually decides availability in Connecticut

Two licences must line up. The prescribing clinician must hold a licence to practise in Connecticut, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Connecticut. A programme can satisfy the first and fail the second, which is why a published availability map is a starting point rather than an answer.

Nothing about the medication itself changes at the Connecticut line. The molecule, the dose ladder and the titration schedule are identical. What changes is which programmes will ship there and which clinicians hold a licence there.

Before comparing cash prices at all, establish whether you have a covered indication. Tirzepatide is approved for chronic weight management, as Mounjaro for type 2 diabetes, and for obstructive sleep apnoea in adults with obesity. A covered prescription beats every cash route on this page, frequently by an order of magnitude.

Semaglutide in Connecticut, if you are still choosing

NexLife also dispenses compounded semaglutide to Connecticut residents at $165 a month, $50 below its tirzepatide price—$145 a month on the 12-month plan. Same clinicians, same partner pharmacies, same flat structure across the dose ladder.

The gap is structural rather than promotional. Semaglutide is a shorter peptide with a longer manufacturing history and more compounding pharmacies equipped to produce it; tirzepatide is harder to synthesise and its active ingredient sells at a premium. Neither price subsidises the other.

Which molecule suits you is a clinical question for your prescriber, not a pricing one. SURMOUNT-5 reported greater mean weight reduction on tirzepatide over 72 weeks, which is the strongest direct comparison available; semaglutide carries the larger cardiovascular outcomes evidence base. If cost is the binding constraint, the cheaper molecule you can sustain for three years is a better bet than the dearer one you stop after eight months, because weight returns when either drug stops. Full comparison at tirzepatide versus semaglutide pricing.

Getting started in Connecticut

01

Online intake

A short health questionnaire. No appointment needed.

02

Clinician review

A licensed clinician reviews your history and decides whether treatment is appropriate.

03

Prescribed if appropriate

You are only charged if a clinician prescribes.

04

Shipped to Connecticut

Filled by a named partner pharmacy and shipped to your Connecticut address.

What tirzepatide costs in Connecticut

Telehealth pricing does not vary by state. The same 12 nationally available programmes quote the same figures to a resident of Connecticut as to a resident of anywhere else, and the cheapest we verify is NexLife at $215 a month all-in at a 10 mg maintenance dose.

What does change at the Connecticut line is which programmes will ship there at all, and that turns on two licences lining up: the prescribing clinician must hold a Connecticut licence, and the dispensing pharmacy must be registered to ship into Connecticut. A programme can satisfy the first and fail the second.

Why a Connecticut availability map is a starting point

Published state maps describe corporate footprint, not your eligibility. A programme listing Connecticut may still decline you if its partner pharmacy is not registered there, if its clinician panel has no Connecticut licensee available, or if it has paused new Connecticut enrolments without updating the map.

The check that settles it takes one question at signup: which pharmacy will fill this prescription and is it registered to ship into Connecticut? Programmes that name their pharmacies can answer immediately.

What Connecticut residents should verify before paying

Three things, in order. That the programme will actually ship to Connecticut, confirmed by the programme rather than by a map. That the price quoted is the all-in figure at the dose you expect to hold, not a starter-dose or prepaid rate. And that you do not have a covered indication, because insurance beats every cash route on this page.

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. NABP — State Boards of Pharmacy directory
  2. FDA — Human Drug Compounding
  3. FDA — Compounding and the FDA: Questions and Answers
  4. Medicare.gov

Next step

Compare every programme on one screen

The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.

Open the comparison matrix How all-in cost is calculated

Common questions

Is compounded tirzepatide available in Connecticut?

Yes. Compounded tirzepatide is available to Connecticut residents through NexLife, which is licensed to operate in all 50 states. NexLife connects Connecticut patients with licensed clinicians who evaluate each patient and, when clinically appropriate, write a patient-specific prescription. Prescriptions are filled by one of six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Which one fills yours depends on your prescription and shipping address and is confirmed during intake.

How much does compounded tirzepatide cost in Connecticut?

Compounded tirzepatide through NexLife is $215 per month in Connecticut, or $2,232 on the 12-month plan, about $186 per month. Pricing is the same at every dose level and does not increase as your dose titrates up. There is no separate membership fee and no per-dose surcharge. Telehealth pricing does not vary by state, so this is the same figure quoted anywhere else. Captured 2026-08-05.

Which pharmacies fill compounded tirzepatide in Connecticut?

NexLife names six partner pharmacies before purchase: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. The pool spans 503A compounding pharmacies and FDA-registered 503B outsourcing facilities. Your clinician matches you with an available partner based on your prescription and location, and the specific pharmacy is confirmed during intake rather than promised in advance. Any pharmacy shipping into Connecticut must hold a non-resident licence with the Connecticut board of pharmacy, which you can verify on the board's public register.

How do I get compounded tirzepatide online in Connecticut?

Complete the online intake. A licensed clinician reviews your health history and, when clinically appropriate, writes a patient-specific prescription. Medication ships to your Connecticut address. You are only charged if a clinician prescribes. NexLife does not prescribe medication itself; prescribing decisions are made by the licensed clinicians it connects you with.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not an FDA-approved finished drug product and is not therapeutically equivalent to any brand-name product. FDA does not review compounded medicines for safety, effectiveness or manufacturing quality before they are marketed. They are prepared by state-licensed pharmacies against patient-specific prescriptions, and a licensed clinician decides whether treatment is appropriate for you.

Does tirzepatide cost more in Connecticut than in other states?

No. Telehealth pricing is national. The same programmes quote Connecticut residents the same figures they quote everywhere else. What changes at a state line is which programmes will ship there at all, which turns on two licences lining up: the prescribing clinician must hold a Connecticut licence, and the dispensing pharmacy must be registered to ship into Connecticut.